Erythromycin as an alternative to reduce interfering extra-cardiac activity in myocardial perfusion imaging.

M Vorster, M M Sathekge, P Rheeder
Author Information
  1. M Vorster: Department Pharmacology, Steve Biko Academic Hospital, University of Pretoria, South Africa. marizavorster@gmail.com

Abstract

OBJECTIVES: We sought to determine whether taking oral erythromycin prior to SPECT myocardial perfusion imaging with Tc99m-sestamibi would reduce the amount of interfering extra-cardiac activity and improve the image quality.
METHODS: A total of 96 patients who were routinely referred for myocardial perfusion imaging were randomly assigned to one of two groups. Patients in group A received 500 mg of non-enterically coated erythromycin orally one hour prior to image acquisition (45 patients). Patients in group B received diluted lemon juice which comprises the current standard of care in our department (51 patients). A two-day protocol was followed and study participants received the same intervention on both days. Planar images of both the stress and rest images were assessed visually by three experienced nuclear medicine physicians for the presence of interfering extracardiac activity. Physicians were blinded to the detail of the protocol and independently assessed the images.
RESULTS: The qualitative results favoured lemon juice in reducing the amount of interfering extra-cardiac activity. The overall incidence of interfering extra-cardiac activity was 46.15% in the lemon juice group vs 55.56% in the erythromycin group. However, this difference was not found to be statistically significant (p = 0.36). The use of a MYO:EXT ratio similar to the one described by Peace and Lloyd,11 appeared promising in quantifying interfering extra-cardiac activity.
CONCLUSION: The difference between the effect of erythromycin and lemon juice on interfering extra-cardiac activity appears statistically insignificant and erythromycin could therefore be considered as a suitable alternative to lemon juice.

References

J Nucl Med. 1989 Mar;30(3):301-11 [PMID: 2525610]
J Nucl Med. 2000 Aug;41(8):1315-7 [PMID: 10945520]
Nucl Med Commun. 2003 Oct;24(10):1105-19 [PMID: 14508167]
J Nucl Cardiol. 2008 Mar-Apr;15(2):241-5 [PMID: 18371596]
Dig Dis Sci. 1992 Nov;37(11):1678-84 [PMID: 1358562]
Antimicrob Agents Chemother. 1996 Aug;40(8):1796-800 [PMID: 8843283]
Nucl Med Commun. 2005 Jan;26(1):17-24 [PMID: 15604943]
Nucl Med Commun. 2006 Dec;27(12):953-7 [PMID: 17088680]
Clin Nucl Med. 1993 Sep;18(9):735-41 [PMID: 8403714]
J Nucl Cardiol. 2003 Mar-Apr;10(2):161-7 [PMID: 12673181]
Radiographics. 2002 May-Jun;22(3):477-90 [PMID: 12006682]
Nucl Med Commun. 2006 Nov;27(11):859-64 [PMID: 17021425]

MeSH Term

Administration, Oral
Artifacts
Beverages
Chi-Square Distribution
Citrus
Coronary Artery Disease
Coronary Circulation
Erythromycin
Female
Fruit
Humans
Image Interpretation, Computer-Assisted
In Vitro Techniques
Male
Middle Aged
Myocardial Perfusion Imaging
Predictive Value of Tests
Radiopharmaceuticals
Reproducibility of Results
Severity of Illness Index
Technetium Tc 99m Sestamibi
Tomography, Emission-Computed, Single-Photon

Chemicals

Radiopharmaceuticals
Erythromycin
Technetium Tc 99m Sestamibi

Word Cloud

Similar Articles

Cited By